Literature DB >> 2865210

Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.

A P Wnek, R J Strouse, B A McClane.   

Abstract

Hybridomas secreting monoclonal antibodies (MABs) specific for Clostridium perfringens type A enterotoxin were produced by fusion of P3X63Ag8.653 myeloma cells with spleen cells from BALB/c mice immunized with purified enterotoxin. Wells containing hybridomas secreting immunoglobulin G (IgG) antibodies against enterotoxin were specifically identified by an indirect enzyme-linked immunosorbent assay (ELISA), and 10 ELISA-positive hybridomas were selected and cloned twice by limiting dilution. All 10 hybridomas produced MABs containing immunoglobulin G1 heavy chains and kappa (kappa) light chains. These hybridomas were then grown as ascitic tumors in mice, and MABs were purified from the ascites fluids with DEAE Affi-gel blue. The specificity of the MABs for enterotoxin was demonstrated by immunoblotting and ELISA. Competitive radioimmunoassay with 125I-MABs suggests that these MABs recognized at least four epitopes on the enterotoxin molecule. The enterotoxin-neutralizing ability of MABs from both hybridoma culture supernatants and ascites fluids was assessed by using a 3H-nucleotide-release Vero (African green monkey kidney) cell assay. Only 2 of the 10 hybridomas produced MABs which completely (greater than 90%) neutralized the biologic activity of enterotoxin. Preincubation of 125I-enterotoxin with MABs demonstrated that MAB neutralizing ability correlated with MAB-specific inhibition of specific binding of enterotoxin to intestinal brush border membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865210      PMCID: PMC261972          DOI: 10.1128/iai.50.2.442-448.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  A hydrophobic form of the small-intestinal sucrase-isomaltase complex.

Authors:  H Sigrist; P Ronner; G Semenza
Journal:  Biochim Biophys Acta       Date:  1975-10-17

2.  The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in Vero cells.

Authors:  B A McClane; J L McDonel
Journal:  J Cell Physiol       Date:  1979-05       Impact factor: 6.384

3.  Binding versus biological activity of Clostridium perfringens enterotoxin in Vero cells.

Authors:  J L McDonel; B A McClane
Journal:  Biochem Biophys Res Commun       Date:  1979-03-30       Impact factor: 3.575

4.  Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts.

Authors:  M Thelestam; R Möllby
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Experimental Diarrhoea in human volunteers following oral administration of Clostridium perfringens enterotoxin.

Authors:  R Skjelkvåle; T Uemura
Journal:  J Appl Bacteriol       Date:  1977-10

7.  Purification and biochemical properties of Clostridium perfringens type A enterotoxin.

Authors:  R L Stark; C L Duncan
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Heterogeneity of enterotoxin-like protein extracted from spores fo Clostridium perfringens type A.

Authors:  W R Frieben; C L Duncan
Journal:  Eur J Biochem       Date:  1975-07-01

10.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

View more
  22 in total

1.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.

Authors:  T A Mietzner; J F Kokai-Kun; P C Hanna; B A McClane
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.

Authors:  S F Little; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

5.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.

Authors:  P C Hanna; A P Wnek; B A McClane
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

8.  Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Clostridium perfringens toxin genotypes in the feces of healthy North Americans.

Authors:  Robert J Carman; Sameera Sayeed; Jihong Li; Christopher W Genheimer; Megan F Hiltonsmith; Tracy D Wilkins; Bruce A McClane
Journal:  Anaerobe       Date:  2008-02-07       Impact factor: 3.331

10.  Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli.

Authors:  J R Czeczulin; P C Hanna; B A McClane
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.